Where it's made
| Factory | Where | Role | Last FDA inspection |
|---|---|---|---|
| Glenmark Pharmaceuticals Limited | Dhar, India | Makes it and tests it | Serious problems, FDA actionFeb 14, 2025 · 8 inspections, 1 with FDA action |
Recalls
- Nov 27, 2018 · Class III · Glenmark Pharmaceuticals Inc., USA
Shortfill: Aprepitant capsules 40 mg is being recalled due to customer reports of missing capsule in the blister pack.
Lots: Lot: 17180918, EXP June 2020
Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.
Product details
- Generic drug
- Aprepitant: every company that makes it
- Form
- capsule, oral
- Strength
- 40 mg
- Approval
- ANDA ANDA207777
- On the market since
- Oct 12, 2017
- Package NDCs
68462-583-1168462-583-4068462-583-85- Official label
- DailyMed (National Library of Medicine), updated Oct 1, 2026
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?